An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas

Journal of Epidemiology and Community Health

Volumn 57, Issue 8, 2003, Pages 634-638

  Marrugat, J ^a,b   D'Agostino, R ^c   Sullivan, L ^c   Elosua, R ^a   Wilson, P ^c   Ordovas, J ^d   Solanas, P ^b,f   Cordon F ^f   Ramos, R ^a   Sala, J ^e   Masia R ^e   Kannel, W B ^c  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c BOSTON UNIVERSITY   (United States)

^d TUFTS UNIVERSITY   (United States)

^e HOSPITAL JOSEP TRUETA   (Spain)

^f Unitat Docent de Medicina de Familia de Girona ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; HEALTH RISK; MEDICAL GEOGRAPHY; RISK FACTOR;

ACCURACY; ADULT; ARTICLE; CARDIOVASCULAR RISK; DEATH; EUROPE; FEMALE; FRAMINGHAM FUNCTION; HEART INFARCTION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREVALENCE; RISK ASSESSMENT;

ADULT; AGED; ALGORITHMS; CORONARY DISEASE; FEMALE; HUMANS; MALE; MEDITERRANEAN REGION; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SPAIN;

SPAIN;

EID: 0041766795     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.57.8.634     Document Type: Article

References (25)

1. Pérez G, Pena A, Sala J, et al, and the REGICOR Investigators. Acute myocardial infarction case fatality, incidence and mortality rates in a population registry in Gerana, Spain, 1990-1992. Int J Epidemiol 1998;27:599-604.
2. Artaud-Wild SM, Connor SL, Sexton G, et al. Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. Circulation 1993;88:2771-9.
3. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, et al. WHO MONICA Project. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994;90:583-612.
4. Masiá R, Pena A, Marrugat J, et al, and the REGICOR Investigators. High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. J Epidemiol Community Health 1998;52:707-15.
5. Martínez de Aragón MV, Llacer A. Mortalidad en España 1995. Boletín Epidemiológico Semanal 1998;6:105-16.
6. Marrugat J, Masiá R, Elosua R, et al. Cardiovascular protective factors: can they explain for the differences in mortality and morbidity between the Mediterranean and the Anglo-Saxon population? Cardiovascular Risk Factors 1998;8:196-204.
7. Marrugat J, Sentí M. Why mortality from heart disease is low in France. High cholesterol may not have the same effect on cardiovascular risk in southern Europe as elsewhere. [Letter]. BMJ 2000;320:7229.
8. Wilson PWF, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47.
9. Kannel WB, Larson M. Long-term epidemiologic prediction of coronary disease. Cardiology 1993;82:137-52.
10. Wallis EJ, Ramsay LE, Haq IU, et al. Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population. BMJ 2000;320:671-6.
11. Verschuren WM, Jacobs DR, Bloemberg BP, et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the Seven Countries Study. JAMA 1995;274:131-6.
12. van den Hoogen PC, Feskens EJ, Nagelkerke NJ, et al. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group. N Engl J Med 2000;342:1-8.
13. D'Agostino RB, Grundy S, Sullivan LM, et al. Validation of the Framingham Coronary Heart Disease Prediction Scores: Results of a Multiple Ethnic Groups Investigation. JAMA 2001;286:180-7.
14. Grundy SM, Balady GJ, Criqui MH, et al. Primary prevention of coronary disease: guidance from Framingham. A statement for healthcare professionals from the AHA Task Force on Risk Reduction. Circulation 1998;97:1876-87.
15. Haq IU, Jackson PR, Yeo WW, et al. Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease. Lancet 1995;346:1467-71.
16. Ramsay LE, Haq IU, Jackson PR, et al. Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table. Lancet 1996;348:387-8.
17. Jackson R. Updated New Zealand cardiovascular disease risk-benefit prediction chart. BMJ 2000;320:709-10.
18. Menotti A, Puddu PE, Lanti M. Comparison of the Framingham risk function-based coronary chart risk function from an Italian population study. Eur Heart J 2000;21:365-70.
19. Ordovas JM. Colesterol y tabaco: clásicos que perduran en el tiempo. Rev Esp Cardiol 2001;54:1143-5.
20. Sentí M, Ordovas JM. Understanding the effects of protective interactions between genetic and environmental factors on cardiovascular ischaemic diseases. Cardiovascular Risk Factors 1998;8:90-7.
21. Anonymous. Tendències de la malaltia coronària a Catalunya, 1985-97: projecte MONICA. Butlleti Epidemiológic de Catalunya 2000;XXI:1-6.
22. Dobson AJ, Evans A, Ferrario M, et al. Changes in estimated coronary risk in the 1980s: data from 38 populations in the WHO MONICA Project. World Health Organization. Monitoring trends and determinants in cardiovascular diseases. Ann Med 1998;30:199-205.
23. Tomas-Abadal L, Varas-Lorenzo C, Bernades-Bernat E, et al. Coronary risk factors and a 20-year incidence of coronary heart disease and mortality in a Mediterranean industrial population. The Manresa Study, Spain. Eur Heart J 1994;15:1028-36.
24. Kannel WB. Silent myocardial ischemia and infarction: insights from the Framingham Study. Cardiol Clin 1986;4:583-91.
25. Sytkowski PA, D'Agostino RB, Belanger A, et al. Sex and time trends in cardiovascular disease incidence and mortality: the Framingham Heart Study 1950-1989. Am J Epidemiol 1996;143:338-50.